The prize is to be bestowed at the Karolinska Stroke Update congress in Stockholm, Sweden, on 12-14 November 2006. A new study on thrombolysis treatment that was conducted simultaneously in 14 European countries will also be presented at the congress.
The international Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST) included 6,483 patients and ran from 2003 to 2006. The international coordinator for the study was Professor Nils Wahlgren at Karolinska Institutet. The researchers expect the results of the study, which is currently under publication, to be of considerable importance to the future application of stroke therapies.
Stroke affects 15 million people around the world every year. Of these, 5 million die and another 5 million are so debilitated by their symptoms that they are unable to cope on their own. One million people suffer strokes in the EU every year, 30,000 of those in Sweden. Given the predicted dramatic rise in the number of elderly people in Europe over the next few decades, scientists expect incidences of stroke to have increased by 50 per cent rise by the middle of this century.
Responding to this greater burden will require coordinated efforts in prevention, acute treatment and rehabilitation. Thrombolysis treatment is given within the first few hours of a stroke to dissolve the blood clots that are blocking part of the brain’s circulatory system.
The Karolinska Stroke Award was first awarded in 2004. The prize was established to reward ground-breaking contributions to stroke research.
Professor Michael Hennerici works at Heidelberg University in Mannheim, Germany. He is awarded the Karolinska Stroke Award for Excellence in Stroke Research for his studies of arteriosclerosis in the blood vessels leading to the brain and its links with stroke, and for the development of his ultrasound diagnostic and treatment techniques for the disease.
Professor Markku Kaste works at Helsinki University Central Hospital, Finland. He is honoured for his leading role in the development of thrombolysis treatment, the first evidence-based treatment of stroke, and for his exceptional ability to put the results of his research into clinical practice.
Professors Markku Kaste and Michael Hennerici are internationally eminent researchers who are both deeply involved in different scientific organisations and collaboration projects. They are also the editors of medical journals. The prize is to be awarded by Susanne Eberstein, chair of the Karolinska Institutet University Board, at Berns in Stockholm on Monday 13 November. The prize money of 100,000 SEK (about 10,800 Euro) will be shared between the two prize winners.
Katarina Sternudd | alfa
Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences
What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy